MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0009023
Digilent Pharmaceuticals Private Limited
Digilent Pharmaceuticals Private Limited - trading in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹72.79 Lakh
▲ 43% YoY
Net profit · FY 2025
₹13,455
Net margin 0.2%
EBITDA · FY 2025
₹17,980
EBITDA margin 0.2%
Authorised capital
₹9.8 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Digilent Pharmaceuticals Private Limited
Data last updated:
Digilent Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC341781. Its GSTIN is 09AAHCD8295L1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹9.8 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivshankar and Mansa Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Nasim Ahmed Shaikh Afsarali Chawl R H No 3 Masjid Road Golibar Santacruz E, Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.79 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹13,455 (net margin 0.2%) and EBITDA of ₹17,980 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Digilent Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0009023).
Company details
CIN U51909MH2020PTC341781
Registration Number 341781
Incorporation Date 12 July 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0009023
Key People
Shivshankar Director Mansa Kumari Director Recognitions & Rankings of Digilent Pharmaceuticals
Contact details
Digilent Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Nasim Ahmed Shaikh Afsarali Chawl R H No 3 Masjid Road Golibar Santacruz E, Mumbai, Maharashtra, India – 400055
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Digilent Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Digilent Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Digilent Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Digilent Pharmaceuticals Private Limited, buy the company report.
Financials of Digilent Pharmaceuticals Private Limited
FY 2025 filings availableDigilent Pharmaceuticals Private Limited reported revenue of ₹72.79 Lakh (up 43% YoY) for FY 2025.
Revenue · FY 2025
₹72.79 Lakh ▲ 43%
Net profit · FY 2025
₹13,455 margin 0.2%
EBITDA · FY 2025
₹17,980 margin 0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 30%
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 43% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17,980 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,455 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Digilent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Digilent Pharmaceuticals Private Limited
Digilent Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivshankar | Director | 12 Jul 2020 | 6 Years 3 Months | Current |
| Mansa Kumari | Director | 26 May 2025 | 1 Years 4 Months | Current |
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2026 | 101220545 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Digilent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Digilent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Digilent Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
Active EPFO establishments
1
GST
Digilent Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD8295L1ZU | Uttar Pradesh | Active | 30 Aug 2020 |
To see the full GST registrations and return filing status of Digilent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Digilent Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Mansa Kumari was appointed as Director on 26 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 101220545 was registered on 16 Jan 2026.
AGM
Digilent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Mansa Kumari was appointed as Director.
Ceased
Santosh Singh ceased to be Director.
Filing
Digilent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Shivshankar was appointed as Director.
Incorporation
12 Jul 2020
Digilent Pharmaceuticals Private Limited was registered on 12 Jul 2020 with Roc Mumbai & aged 6 years 3 months as per MCA records.
Frequently asked questions
Digilent Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 12 July 2020 (6+ years old) and is registered under CIN U51909MH2020PTC341781.
Digilent Pharmaceuticals has 2 current directors:
- Shivshankar - Director
- Mansa Kumari - Director
The latest financial statements of Digilent Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Digilent Pharmaceuticals is 09AAHCD8295L1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Digilent Pharmaceuticals is U51909MH2020PTC341781. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Digilent Pharmaceuticals was incorporated on 12 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Mansa Kumari was appointed as Director on 26 May 2025. Santosh Singh ceased to be Director on 26 May 2025. Shivshankar was appointed as Director on 12 Jul 2020.
Yes, Digilent Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0009023).
The registered office of Digilent Pharmaceuticals is at CO Nasim Ahmed Shaikh Afsarali Chawl R H No 3 Masjid Road Golibar Santacruz E, Mumbai, Maharashtra, India – 400055.
Digilent Pharmaceuticals operates in the trading industry, in the specialty segment.